NYSE: IBMInternational Business Machines Corp Stock
$253.69+4.49 (+1.8%)
Updated May 12, 2025
IBM Price
$253.69
Fair Value Price
N/A
Market Cap
$235.78B
52 Week Low
$163.53
52 Week High
$266.45
P/E
42.78x
P/B
8.77x
P/S
3.67x
PEG
1.17x
Dividend Yield
2.64%
Revenue
$62.83B
Earnings
$5.47B
Gross Margin
57%
Operating Margin
12.09%
Profit Margin
8.7%
Debt to Equity
4.42
Operating Cash Flow
$14B
Beta
0.66
Next Earnings
N/A
Ex-Dividend
May 9, 2025
Next Dividend
Jun 10, 2025
IBM Overview
International Business Machines Corporation (IBM) manufactures computer hardware, middleware, and software, and provides hosting and consulting services in areas ranging from mainframe computers to nanotechnology. Inventions by IBM include the automated teller machine (ATM), the floppy disk, the hard disk drive, the magnetic stripe card, the relational database, the SQL programming language, the UPC barcode, and dynamic random-access memory (DRAM). The company was founded in 1911 and is headquartered in Armonk, NY.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine IBM's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Information Technology Service
Industry Rating
A
IBM
Ranked#27 of 58
Ranked#27 of 58
Be the first to know about important IBM news, forecast changes, insider trades & much more!
IBM News
Overview
Due Diligence Score
–
Industry Average (36)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how IBM scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
IBM ($253.69) is trading above its intrinsic value of $107.07, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
IBM is poor value based on its earnings relative to its share price (42.78x), compared to the US market average (24.73x)
P/E vs Market Valuation
IBM is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more IBM due diligence checks available for Premium users.
Valuation
IBM price to earnings (PE)
For valuing profitable companies with steady earnings
Company
42.78x
Industry
28.18x
Market
24.73x
IBM is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
IBM is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
IBM price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
8.77x
Industry
5.1x
IBM is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
IBM price to earnings growth (PEG)
For valuing profitable companies with growth potential
IBM is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
IBM's financial health
Profit margin
Revenue
$14.5B
Net Income
$1.1B
Profit Margin
7.3%
IBM's Earnings (EBIT) of $7.59B... subscribe to Premium to read more.
Interest Coverage Financials
IBM's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$145.7B
Liabilities
$118.7B
Debt to equity
4.42
IBM's short-term assets ($35.34B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
IBM's long-term liabilities ($83.61B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
IBM's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
IBM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$4.4B
Investing
-$13.0B
Financing
$5.4B
IBM's operating cash flow ($13.65B)... subscribe to Premium to read more.
Debt Coverage Financials
IBM vs Information Technology Service Stocks
IBM Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.